About Forkhead box protein C2
Forkhead box protein C2 (FOXC2) is a protein
from Homo sapiens identified by UniProt accession
Q99958, 501 residues long.
MolForge cross-references it against 0 known binders and
372 disease associations.
Target properties
| Protein name | Forkhead box protein C2 |
| UniProt accession | Q99958 |
| Gene | FOXC2 |
| Organism | Homo sapiens |
| Length | 501 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (372)
Diseases linked to this target (Open Targets).
- lymphedema-distichiasis syndrome · score 0.82
- Lymphedema - distichiasis · score 0.75
- genetic disorder · score 0.41
- hydrops fetalis · score 0.38
- Cleft palate · score 0.38
- cleft palate · score 0.37
- neuroinflammatory disorder · score 0.37
- neurodegenerative disease · score 0.37
- heel bone mineral density · score 0.35
- bone density · score 0.34
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q99958-F1 | alphafold | PREDICTED | 55.16 | — |
Amino-acid sequence (501 residues)
MQARYSVSDP NALGVVPYLS EQNYYRAAGS YGGMASPMGV YSGHPEQYSA GMGRSYAPYH HHQPAAPKDL VKPPYSYIAL ITMAIQNAPE KKITLNGIYQ FIMDRFPFYR ENKQGWQNSI RHNLSLNECF VKVPRDDKKP GKGSYWTLDP DSYNMFENGS FLRRRRRFKK KDVSKEKEER AHLKEPPPAA SKGAPATPHL ADAPKEAEKK VVIKSEAASP ALPVITKVET LSPESALQGS PRSAASTPAG SPDGSLPEHH AAAPNGLPGF SVENIMTLRT SPPGGELSPG AGRAGLVVPP LALPYAAAPP AAYGQPCAQG LEAGAAGGYQ CSMRAMSLYT GAERPAHMCV PPALDEALSD HPSGPTSPLS ALNLAAGQEG ALAATGHHHQ HHGHHHPQAP PPPPAPQPQP TPQPGAAAAQ AASWYLNHSG DLNHLPGHTF AAQQQTFPNV REMFNSHRLG IENSTLGESQ VSGNASCQLP YRSTPPLYRH AAPYSYDCTK Y
Explore Forkhead box protein C2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets